Mereo BioPharma Group plc
NASDAQ:MREOBiotechnology
Healthcare
$0.32 +9.69%
+$0.03 today
- Market cap
- $51.08M
- Beta
- 0.28
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$0.22
52W Low $0.20High $3.05
Volume 1.26M
Average 3.36M
Price history
Mereo BioPharma Group plc SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-82.42%
Period high
$2.31
Period low
$0.24
Latest
$0.32
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Aug 19, 2026 | Aug 19, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| 10-Q | Aug 11, 2026 | Aug 11, 2026 | |
| 8-K | Aug 11, 2026 | Aug 11, 2026 | |
| 8-K | Aug 11, 2026 | Aug 11, 2026 | |
| SC 13G/A | May 15, 2026 | May 15, 2026 | |
| SC 13G | May 14, 2026 | May 14, 2026 | |
| 8-K | May 14, 2026 | May 14, 2026 | |
| 8-K/A | May 12, 2026 | May 12, 2026 | |
| 8-K | May 12, 2026 | May 12, 2026 | |
| 10-Q | May 12, 2026 | May 12, 2026 | |
| ARS | Apr 9, 2026 | Apr 9, 2026 | |
| DEF 14A | Apr 9, 2026 | Apr 9, 2026 | |
| 8-K | Mar 27, 2026 | Mar 27, 2026 | |
| PRE 14A | Mar 27, 2026 | Mar 27, 2026 |
Competitors
Who does Mereo BioPharma Group plc compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about MREO's filings, answered from its disclosures.
What is the latest MREO filing?
The latest filing shown is 8-K dated Aug 19, 2026.
How many recent filings does MREO have?
Intrinsic Alpha currently shows 20 recent filings for MREO.
Continue the stock analysis
Jump to another research area for this company.